<DOC>
	<DOCNO>NCT02436486</DOCNO>
	<brief_summary>To evaluate effect idalopirdine ( 120 360 mg ) cardiac repolarisation healthy men .</brief_summary>
	<brief_title>Study Investigating Effect Idalopirdine Cardiac Repolarisation Healthy Men</brief_title>
	<detailed_description />
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Body weight least 50 kg Body Mass index &gt; 18.5 &lt; 30 kg/m2 Good general health ascertain detailed medical history , laboratory test physical examination Use contraception . The subject evidence cardiac conduction abnormality calculate ECG equipment evaluate investigator , Screening Visit Baseline visit The subject history long QT syndrome , history cardiac arrhythmia , history cardiac disease ( eg , coronary artery disease , valvular disease , etc. ) . Other protocol define inclusion exclusion criterion apply</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>